nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—PDE5A—clitoris—ovarian cancer	0.208	0.659	CbGeAlD
Tadalafil—CYP3A4—Topotecan—ovarian cancer	0.0521	0.354	CbGbCtD
Tadalafil—CYP3A4—Vinorelbine—ovarian cancer	0.0367	0.25	CbGbCtD
Tadalafil—PDE11A—epithelium—ovarian cancer	0.0271	0.0862	CbGeAlD
Tadalafil—CYP3A4—Paclitaxel—ovarian cancer	0.0258	0.175	CbGbCtD
Tadalafil—CYP3A4—Docetaxel—ovarian cancer	0.0186	0.127	CbGbCtD
Tadalafil—PDE11A—testis—ovarian cancer	0.0163	0.0517	CbGeAlD
Tadalafil—CYP3A4—Doxorubicin—ovarian cancer	0.0139	0.0945	CbGbCtD
Tadalafil—PDE5A—epithelium—ovarian cancer	0.0103	0.0328	CbGeAlD
Tadalafil—PDE5A—uterine cervix—ovarian cancer	0.0102	0.0325	CbGeAlD
Tadalafil—PDE5A—gonad—ovarian cancer	0.00859	0.0273	CbGeAlD
Tadalafil—PDE5A—female reproductive system—ovarian cancer	0.00767	0.0244	CbGeAlD
Tadalafil—PDE5A—female gonad—ovarian cancer	0.00698	0.0222	CbGeAlD
Tadalafil—PDE5A—vagina—ovarian cancer	0.00694	0.022	CbGeAlD
Tadalafil—PDE5A—testis—ovarian cancer	0.00619	0.0197	CbGeAlD
Tadalafil—PDE5A—lymph node—ovarian cancer	0.00449	0.0143	CbGeAlD
Tadalafil—CYP3A4—female reproductive system—ovarian cancer	0.00239	0.0076	CbGeAlD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000668	0.00124	CcSEcCtD
Tadalafil—Nausea—Topotecan—ovarian cancer	0.000665	0.00124	CcSEcCtD
Tadalafil—Discomfort—Paclitaxel—ovarian cancer	0.000664	0.00123	CcSEcCtD
Tadalafil—Gastritis—Epirubicin—ovarian cancer	0.000663	0.00123	CcSEcCtD
Tadalafil—Dry mouth—Paclitaxel—ovarian cancer	0.000657	0.00122	CcSEcCtD
Tadalafil—Diarrhoea—Vinorelbine—ovarian cancer	0.000656	0.00122	CcSEcCtD
Tadalafil—Nausea—Melphalan—ovarian cancer	0.000651	0.00121	CcSEcCtD
Tadalafil—Influenza—Epirubicin—ovarian cancer	0.000648	0.0012	CcSEcCtD
Tadalafil—Dysphagia—Epirubicin—ovarian cancer	0.000648	0.0012	CcSEcCtD
Tadalafil—Back pain—Docetaxel—ovarian cancer	0.000647	0.0012	CcSEcCtD
Tadalafil—Oedema—Paclitaxel—ovarian cancer	0.000644	0.0012	CcSEcCtD
Tadalafil—Muscle spasms—Docetaxel—ovarian cancer	0.000643	0.0012	CcSEcCtD
Tadalafil—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00064	0.00119	CcSEcCtD
Tadalafil—Infection—Paclitaxel—ovarian cancer	0.00064	0.00119	CcSEcCtD
Tadalafil—Shock—Paclitaxel—ovarian cancer	0.000634	0.00118	CcSEcCtD
Tadalafil—Dizziness—Vinorelbine—ovarian cancer	0.000634	0.00118	CcSEcCtD
Tadalafil—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000633	0.00118	CcSEcCtD
Tadalafil—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000633	0.00118	CcSEcCtD
Tadalafil—Nervous system disorder—Paclitaxel—ovarian cancer	0.000632	0.00117	CcSEcCtD
Tadalafil—Angina pectoris—Epirubicin—ovarian cancer	0.000631	0.00117	CcSEcCtD
Tadalafil—Tachycardia—Paclitaxel—ovarian cancer	0.000629	0.00117	CcSEcCtD
Tadalafil—Breast disorder—Doxorubicin—ovarian cancer	0.000627	0.00116	CcSEcCtD
Tadalafil—Skin disorder—Paclitaxel—ovarian cancer	0.000626	0.00116	CcSEcCtD
Tadalafil—Bronchitis—Epirubicin—ovarian cancer	0.000623	0.00116	CcSEcCtD
Tadalafil—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000623	0.00116	CcSEcCtD
Tadalafil—Nasopharyngitis—Doxorubicin—ovarian cancer	0.00062	0.00115	CcSEcCtD
Tadalafil—Gastritis—Doxorubicin—ovarian cancer	0.000614	0.00114	CcSEcCtD
Tadalafil—Vomiting—Vinorelbine—ovarian cancer	0.000609	0.00113	CcSEcCtD
Tadalafil—Rash—Vinorelbine—ovarian cancer	0.000604	0.00112	CcSEcCtD
Tadalafil—Dermatitis—Vinorelbine—ovarian cancer	0.000604	0.00112	CcSEcCtD
Tadalafil—Hypotension—Paclitaxel—ovarian cancer	0.000602	0.00112	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000602	0.00112	CcSEcCtD
Tadalafil—Headache—Vinorelbine—ovarian cancer	0.0006	0.00112	CcSEcCtD
Tadalafil—Syncope—Docetaxel—ovarian cancer	0.0006	0.00112	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—ovarian cancer	0.000599	0.00111	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—ovarian cancer	0.000599	0.00111	CcSEcCtD
Tadalafil—Palpitations—Docetaxel—ovarian cancer	0.000591	0.0011	CcSEcCtD
Tadalafil—Loss of consciousness—Docetaxel—ovarian cancer	0.000588	0.00109	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000587	0.00109	CcSEcCtD
Tadalafil—Cough—Docetaxel—ovarian cancer	0.000584	0.00109	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—ovarian cancer	0.000584	0.00109	CcSEcCtD
Tadalafil—Insomnia—Paclitaxel—ovarian cancer	0.000583	0.00108	CcSEcCtD
Tadalafil—Convulsion—Docetaxel—ovarian cancer	0.00058	0.00108	CcSEcCtD
Tadalafil—Paraesthesia—Paclitaxel—ovarian cancer	0.000579	0.00108	CcSEcCtD
Tadalafil—Hypertension—Docetaxel—ovarian cancer	0.000578	0.00107	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—ovarian cancer	0.000578	0.00107	CcSEcCtD
Tadalafil—Infestation—Epirubicin—ovarian cancer	0.000578	0.00107	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—ovarian cancer	0.000577	0.00107	CcSEcCtD
Tadalafil—Dyspnoea—Paclitaxel—ovarian cancer	0.000575	0.00107	CcSEcCtD
Tadalafil—Somnolence—Paclitaxel—ovarian cancer	0.000573	0.00106	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000573	0.00106	CcSEcCtD
Tadalafil—Chest pain—Docetaxel—ovarian cancer	0.00057	0.00106	CcSEcCtD
Tadalafil—Myalgia—Docetaxel—ovarian cancer	0.00057	0.00106	CcSEcCtD
Tadalafil—Arthralgia—Docetaxel—ovarian cancer	0.00057	0.00106	CcSEcCtD
Tadalafil—Nausea—Vinorelbine—ovarian cancer	0.000569	0.00106	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—ovarian cancer	0.000568	0.00106	CcSEcCtD
Tadalafil—Dyspepsia—Paclitaxel—ovarian cancer	0.000567	0.00105	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000566	0.00105	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—ovarian cancer	0.000562	0.00104	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—ovarian cancer	0.000562	0.00104	CcSEcCtD
Tadalafil—Dry mouth—Docetaxel—ovarian cancer	0.000557	0.00104	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000557	0.00104	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000556	0.00103	CcSEcCtD
Tadalafil—Fatigue—Paclitaxel—ovarian cancer	0.000556	0.00103	CcSEcCtD
Tadalafil—Sweating—Epirubicin—ovarian cancer	0.000554	0.00103	CcSEcCtD
Tadalafil—Pain—Paclitaxel—ovarian cancer	0.000551	0.00102	CcSEcCtD
Tadalafil—Constipation—Paclitaxel—ovarian cancer	0.000551	0.00102	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—ovarian cancer	0.000551	0.00102	CcSEcCtD
Tadalafil—Oedema—Docetaxel—ovarian cancer	0.000546	0.00101	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—ovarian cancer	0.000545	0.00101	CcSEcCtD
Tadalafil—Infection—Docetaxel—ovarian cancer	0.000543	0.00101	CcSEcCtD
Tadalafil—Shock—Docetaxel—ovarian cancer	0.000537	0.000999	CcSEcCtD
Tadalafil—Nervous system disorder—Docetaxel—ovarian cancer	0.000536	0.000995	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—ovarian cancer	0.000535	0.000993	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—ovarian cancer	0.000535	0.000993	CcSEcCtD
Tadalafil—Tachycardia—Docetaxel—ovarian cancer	0.000533	0.000991	CcSEcCtD
Tadalafil—Skin disorder—Docetaxel—ovarian cancer	0.000531	0.000986	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00053	0.000985	CcSEcCtD
Tadalafil—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000527	0.000979	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—ovarian cancer	0.000525	0.000976	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—ovarian cancer	0.000521	0.000969	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—ovarian cancer	0.00052	0.000966	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—ovarian cancer	0.00052	0.000965	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—ovarian cancer	0.00052	0.000965	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—ovarian cancer	0.000519	0.000964	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—ovarian cancer	0.000516	0.000959	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—ovarian cancer	0.000515	0.000956	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—ovarian cancer	0.000512	0.000952	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—ovarian cancer	0.000512	0.000952	CcSEcCtD
Tadalafil—Urticaria—Paclitaxel—ovarian cancer	0.000512	0.000951	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—ovarian cancer	0.000511	0.000949	CcSEcCtD
Tadalafil—Hypotension—Docetaxel—ovarian cancer	0.00051	0.000948	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—ovarian cancer	0.00051	0.000947	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—ovarian cancer	0.00051	0.000947	CcSEcCtD
Tadalafil—Abdominal pain—Paclitaxel—ovarian cancer	0.000509	0.000947	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—ovarian cancer	0.000508	0.000945	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—ovarian cancer	0.000504	0.000937	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000498	0.000925	CcSEcCtD
Tadalafil—Insomnia—Docetaxel—ovarian cancer	0.000494	0.000918	CcSEcCtD
Tadalafil—Paraesthesia—Docetaxel—ovarian cancer	0.00049	0.000911	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—ovarian cancer	0.00049	0.000911	CcSEcCtD
Tadalafil—Dyspnoea—Docetaxel—ovarian cancer	0.000487	0.000905	CcSEcCtD
Tadalafil—Somnolence—Docetaxel—ovarian cancer	0.000486	0.000902	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—ovarian cancer	0.000485	0.000901	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—ovarian cancer	0.000484	0.000898	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—ovarian cancer	0.000482	0.000896	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—ovarian cancer	0.000481	0.000894	CcSEcCtD
Tadalafil—Flushing—Epirubicin—ovarian cancer	0.000481	0.000894	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—ovarian cancer	0.000481	0.000894	CcSEcCtD
Tadalafil—Dyspepsia—Docetaxel—ovarian cancer	0.000481	0.000893	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—ovarian cancer	0.00048	0.000892	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000477	0.000887	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—ovarian cancer	0.000476	0.000885	CcSEcCtD
Tadalafil—Hypersensitivity—Paclitaxel—ovarian cancer	0.000475	0.000882	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000474	0.000881	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—ovarian cancer	0.000473	0.000878	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000472	0.000876	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000472	0.000876	CcSEcCtD
Tadalafil—Fatigue—Docetaxel—ovarian cancer	0.000471	0.000875	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—ovarian cancer	0.000471	0.000874	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—ovarian cancer	0.00047	0.000874	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—ovarian cancer	0.000468	0.00087	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—ovarian cancer	0.000467	0.000868	CcSEcCtD
Tadalafil—Constipation—Docetaxel—ovarian cancer	0.000467	0.000868	CcSEcCtD
Tadalafil—Pain—Docetaxel—ovarian cancer	0.000467	0.000868	CcSEcCtD
Tadalafil—Asthenia—Paclitaxel—ovarian cancer	0.000462	0.000859	CcSEcCtD
Tadalafil—Pruritus—Paclitaxel—ovarian cancer	0.000456	0.000847	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—ovarian cancer	0.000454	0.000844	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—ovarian cancer	0.000454	0.000843	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—ovarian cancer	0.000448	0.000833	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—ovarian cancer	0.000447	0.000831	CcSEcCtD
Tadalafil—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000447	0.00083	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—ovarian cancer	0.000445	0.000827	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—ovarian cancer	0.000445	0.000827	CcSEcCtD
Tadalafil—Diarrhoea—Paclitaxel—ovarian cancer	0.000441	0.000819	CcSEcCtD
Tadalafil—Back pain—Epirubicin—ovarian cancer	0.000437	0.000811	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—ovarian cancer	0.000435	0.000809	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—ovarian cancer	0.000434	0.000806	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—ovarian cancer	0.000433	0.000805	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000432	0.000804	CcSEcCtD
Tadalafil—Abdominal pain—Docetaxel—ovarian cancer	0.000432	0.000802	CcSEcCtD
Tadalafil—Dizziness—Paclitaxel—ovarian cancer	0.000426	0.000792	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—ovarian cancer	0.000425	0.000791	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—ovarian cancer	0.00042	0.000781	CcSEcCtD
Tadalafil—Vomiting—Paclitaxel—ovarian cancer	0.00041	0.000761	CcSEcCtD
Tadalafil—Rash—Paclitaxel—ovarian cancer	0.000406	0.000755	CcSEcCtD
Tadalafil—Dermatitis—Paclitaxel—ovarian cancer	0.000406	0.000754	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—ovarian cancer	0.000406	0.000754	CcSEcCtD
Tadalafil—Syncope—Epirubicin—ovarian cancer	0.000405	0.000752	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—ovarian cancer	0.000404	0.000751	CcSEcCtD
Tadalafil—Headache—Paclitaxel—ovarian cancer	0.000404	0.00075	CcSEcCtD
Tadalafil—Hypersensitivity—Docetaxel—ovarian cancer	0.000402	0.000748	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—ovarian cancer	0.000402	0.000746	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—ovarian cancer	0.000399	0.000741	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—ovarian cancer	0.000397	0.000737	CcSEcCtD
Tadalafil—Cough—Epirubicin—ovarian cancer	0.000394	0.000732	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—ovarian cancer	0.000394	0.000731	CcSEcCtD
Tadalafil—Asthenia—Docetaxel—ovarian cancer	0.000392	0.000728	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—ovarian cancer	0.000391	0.000727	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—ovarian cancer	0.00039	0.000724	CcSEcCtD
Tadalafil—Pruritus—Docetaxel—ovarian cancer	0.000386	0.000718	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—ovarian cancer	0.000384	0.000714	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—ovarian cancer	0.000384	0.000714	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—ovarian cancer	0.000384	0.000714	CcSEcCtD
Tadalafil—Nausea—Paclitaxel—ovarian cancer	0.000383	0.000711	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000382	0.000709	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—ovarian cancer	0.00038	0.000706	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—ovarian cancer	0.000376	0.000698	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—ovarian cancer	0.000375	0.000697	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—ovarian cancer	0.000375	0.000696	CcSEcCtD
Tadalafil—Diarrhoea—Docetaxel—ovarian cancer	0.000374	0.000694	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—ovarian cancer	0.000369	0.000686	CcSEcCtD
Tadalafil—Oedema—Epirubicin—ovarian cancer	0.000368	0.000685	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—ovarian cancer	0.000367	0.000682	CcSEcCtD
Tadalafil—Infection—Epirubicin—ovarian cancer	0.000366	0.00068	CcSEcCtD
Tadalafil—Cough—Doxorubicin—ovarian cancer	0.000364	0.000677	CcSEcCtD
Tadalafil—Shock—Epirubicin—ovarian cancer	0.000362	0.000674	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—ovarian cancer	0.000362	0.000672	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—ovarian cancer	0.000361	0.000671	CcSEcCtD
Tadalafil—Dizziness—Docetaxel—ovarian cancer	0.000361	0.000671	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—ovarian cancer	0.000361	0.00067	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—ovarian cancer	0.00036	0.000668	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—ovarian cancer	0.000358	0.000665	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—ovarian cancer	0.000356	0.000662	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—ovarian cancer	0.000356	0.000661	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—ovarian cancer	0.000356	0.000661	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—ovarian cancer	0.000356	0.000661	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000353	0.000656	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—ovarian cancer	0.000351	0.000653	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—ovarian cancer	0.000348	0.000646	CcSEcCtD
Tadalafil—Vomiting—Docetaxel—ovarian cancer	0.000347	0.000645	CcSEcCtD
Tadalafil—Rash—Docetaxel—ovarian cancer	0.000344	0.00064	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—ovarian cancer	0.000344	0.00064	CcSEcCtD
Tadalafil—Dermatitis—Docetaxel—ovarian cancer	0.000344	0.000639	CcSEcCtD
Tadalafil—Headache—Docetaxel—ovarian cancer	0.000342	0.000636	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—ovarian cancer	0.000341	0.000633	CcSEcCtD
Tadalafil—Infection—Doxorubicin—ovarian cancer	0.000339	0.000629	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000336	0.000624	CcSEcCtD
Tadalafil—Shock—Doxorubicin—ovarian cancer	0.000335	0.000623	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—ovarian cancer	0.000334	0.000621	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—ovarian cancer	0.000333	0.000619	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—ovarian cancer	0.000333	0.000618	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—ovarian cancer	0.000331	0.000615	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—ovarian cancer	0.000331	0.000615	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00033	0.000612	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—ovarian cancer	0.000328	0.00061	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—ovarian cancer	0.000328	0.000609	CcSEcCtD
Tadalafil—Nausea—Docetaxel—ovarian cancer	0.000324	0.000603	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—ovarian cancer	0.000324	0.000603	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—ovarian cancer	0.000319	0.000592	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000318	0.000591	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—ovarian cancer	0.000318	0.00059	CcSEcCtD
Tadalafil—Constipation—Epirubicin—ovarian cancer	0.000315	0.000585	CcSEcCtD
Tadalafil—Pain—Epirubicin—ovarian cancer	0.000315	0.000585	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000311	0.000577	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—ovarian cancer	0.000308	0.000573	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—ovarian cancer	0.000306	0.000569	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—ovarian cancer	0.000304	0.000565	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—ovarian cancer	0.000303	0.000563	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000301	0.00056	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—ovarian cancer	0.0003	0.000558	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000294	0.000547	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—ovarian cancer	0.000294	0.000546	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—ovarian cancer	0.000293	0.000544	CcSEcCtD
Tadalafil—Pain—Doxorubicin—ovarian cancer	0.000292	0.000542	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—ovarian cancer	0.000292	0.000542	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—ovarian cancer	0.000291	0.000541	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000279	0.000518	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—ovarian cancer	0.000271	0.000504	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—ovarian cancer	0.000271	0.000503	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—ovarian cancer	0.000269	0.000501	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—ovarian cancer	0.000264	0.000491	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—ovarian cancer	0.000261	0.000484	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—ovarian cancer	0.000252	0.000468	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—ovarian cancer	0.000251	0.000467	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—ovarian cancer	0.000245	0.000454	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—ovarian cancer	0.000244	0.000453	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—ovarian cancer	0.000241	0.000448	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—ovarian cancer	0.000234	0.000435	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—ovarian cancer	0.000233	0.000433	CcSEcCtD
Tadalafil—Rash—Epirubicin—ovarian cancer	0.000232	0.000432	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—ovarian cancer	0.000232	0.000431	CcSEcCtD
Tadalafil—Headache—Epirubicin—ovarian cancer	0.000231	0.000429	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—ovarian cancer	0.000225	0.000419	CcSEcCtD
Tadalafil—Nausea—Epirubicin—ovarian cancer	0.000219	0.000407	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—ovarian cancer	0.000217	0.000403	CcSEcCtD
Tadalafil—Rash—Doxorubicin—ovarian cancer	0.000215	0.000399	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—ovarian cancer	0.000215	0.000399	CcSEcCtD
Tadalafil—Headache—Doxorubicin—ovarian cancer	0.000214	0.000397	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—ovarian cancer	0.000202	0.000376	CcSEcCtD
